Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease. (linkinghub.elsevier.com)

Authors: Klatt D … Brendel C Journal: Cell Stem Cell Published: 2026-09-24 DOI: https://doi.org/10.1016/j.stem.2026.09.001